The Antinociceptive Effect of Magnesium Sulphate Administered in the Epidural Space in Standing Horses.
Authors: La Rosa Lavinia, Twele Lara, Duchateau Luc, Gasthuys Frank, Kästner Sabine Br, Schauvliege Stijn
Journal: Journal of equine veterinary science
Summary
# Editorial Summary: Epidural Magnesium Sulphate for Analgesia in Standing Horses Magnesium's role as an NMDA receptor antagonist makes it theoretically attractive for pain management, yet its antinociceptive properties remain poorly characterised in equine epidural applications. La Rosa and colleagues investigated whether epidural magnesium sulphate (MgSO₄) could modulate nociceptive thresholds in standing horses using a masked, placebo-controlled cross-over design; six healthy horses received either 1 mg/kg MgSO₄ diluted to 15 mL or saline via epidural catheter, with electrical, thermal and mechanical nociceptive thresholds assessed repeatedly over 180 minutes. The treatment successfully increased electrical nociceptive thresholds (P = 0.0001), suggesting genuine antinociceptive activity, yet produced no significant effects on thermal or mechanical thresholds—indicating selective and incomplete analgesia across pain modalities. Significantly, two horses collapsed during MgSO₄ administration, with one excluded from the study, and heart rate remained elevated at 180 minutes (44 ± 23 vs 32 ± 9 beats/min; P = 0.009), raising serious safety concerns. Whilst the selective electrical threshold elevation warrants further investigation into mechanism, the current dosing protocol appears unsuitable for clinical use without substantial refinement, and practitioners should exercise considerable caution pending higher-quality efficacy and safety data.
Read the full abstract on PubMed
Practical Takeaways
- •Epidural magnesium sulphate shows limited antinociceptive benefit—only electrical threshold increased, not thermal or mechanical pain responses that matter clinically
- •Serious safety concern: 33% collapse rate during injection is unacceptable for standing procedures; this dose and route cannot be recommended for clinical use without major modifications
- •If considering epidural MgSO4 experimentally, recognition of collapse risk and elevated heart rate response are mandatory safety considerations requiring immediate intervention capability
Key Findings
- •Epidural MgSO4 at 1 mg/kg caused significant increase in electrical nociceptive threshold (P=0.0001) in pelvic limbs of standing horses
- •No significant differences found in thermal or mechanical nociceptive thresholds with epidural MgSO4 treatment
- •Adverse safety concern: 2 of 6 horses collapsed during MgSO4 injection; 1 recovered within 20 minutes, 1 had to be excluded from study
- •Heart rate significantly elevated at 180 minutes post-MgSO4 (44±23 bpm) compared to saline control (32±9 bpm, P=0.0090)